Private Capital Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Private Capital Advisors's IBRX Position: Q3 2026 in Review
Private Capital Advisors reduced its ImmunityBio (IBRX) stake by 0.46% in Q3 2026, selling an estimated $999 and leaving 26,853 shares worth $253K. The position accounts for 0.02% of the portfolio, ranked #68.
Private Capital Advisors first reported a position in IBRX in Q1 2026 and has held it in 3 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Private Capital Advisors held 26,853 shares of ImmunityBio worth $253K as of Q3 2026.
- Private Capital Advisors sold 125 ImmunityBio shares in Q3 2026, an estimated $999.
- ImmunityBio made up 0.02% of Private Capital Advisors's portfolio in Q3 2026, its #68 holding.
- Private Capital Advisors first reported a position in ImmunityBio in Q1 2026 and has held it in 3 quarters since.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Private Capital Advisors's 13F filing for Q3 2026, filed 6 Oct 2026.